NSI-189
NSI-189 Phosphate
NSI-189
NSI-189 is a synthetic compound that people are interested in because it appears to do something most psychiatric medications can't: actually grow new brain cells. Specifically, it seems to build new neurons in your hippocampus, the part of your brain that handles memory and emotion. People have reported significant improvements in mood, mental clarity, and how they process emotions, which is why it's generated so much interest in research communities, even though it's still experimental.
Here's how it actually works in your body. When you take NSI-189, it triggers your brain to create fresh neurons in that hippocampus region—something researchers can actually see on brain scans as increased volume, which is pretty remarkable. It does this through mechanisms scientists are still pinning down, but it appears to directly encourage your neural stem cells to multiply and mature into functional neurons, working through different pathways than typical antidepressants. At the same time, it also adjusts your serotonin signaling—the same neurotransmitter system that drugs like SSRIs target—and increases the connections between existing neurons. So you're getting both long-term structural changes to your brain through neurogenesis and more immediate chemical adjustments to your mood and thinking, all happening simultaneously.
Dosage Information
Typical Dose
40-80 mg daily
Frequency
Once or twice daily
Administration
Oral capsule
Half-Life
6–8 hours
Notes
Phase 1b used 40mg and 80mg daily doses. Research community typically uses 40mg daily. Cycles of 8-12 weeks with breaks recommended.
Why this matters
Moderate oral half-life; once or twice daily dosing in clinical trials.
Protocol cycle
Where does NSI-189 sit?
See how this peptide compares across all 150 peptides in our database.
Evidence Score
0.36
Compound Data
Molecular Formula
C22H30N4O
Molecular Weight
366.50 g/mol
IUPAC Name
(4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)-3-pyridinyl]methanone
PubChem CID
50922681Potential Side Effects
NSI-189 discussions
Quick Facts
- Administration
- Oral capsule
- Typical Dose
- 40-80 mg daily
- Frequency
- Once or twice daily
- References
- 0 curated + 1 from PubMed
- Clinical Trials
- 4 registered
- Evidence Score
- 0.4 / 100
Frequently Asked Questions about NSI-189
What is NSI-189?
NSI-189 is a synthetic aminopyridine-benzylpiperazine compound originally developed by Neuralstem Inc that has demonstrated neurogenic properties in the hippocampus and antidepressant effects in clinical trials. It completed a Phase 1b trial for major depressive disorder and a Phase 2 trial that showed improvements in cognitive function though with mixed results on the primary depression endpoint. NSI-189 is notable in the research community for subjective reports of significant improvements in mood memory emotional processing and cognitive clarity that have made it one of the most discussed experimental neurological compounds.
How does NSI-189 work?
NSI-189 stimulates neurogenesis in the human hippocampus through mechanisms that are not yet fully characterized but appear to involve direct effects on neural stem cell proliferation and differentiation independent of classic neurotrophic factor pathways. In the Phase 1b trial participants showed increased hippocampal volume on MRI — a rare finding for any pharmacological intervention and a strong indicator of genuine neurogenic activity. NSI-189 also modulates serotonergic signaling and has been shown to increase synaptic density in hippocampal regions. The antidepressant effects may be mediated through both neurogenesis-dependent mechanisms similar to how SSRIs are thought to work long-term and more immediate effects on monoamine neurotransmission.
What is the recommended dosage for NSI-189?
The typical dose is 40-80 mg daily. Once or twice daily. Administration: Oral capsule. Phase 1b used 40mg and 80mg daily doses. Research community typically uses 40mg daily. Cycles of 8-12 weeks with breaks recommended.
What are the side effects of NSI-189?
Headache (common in clinical trials). Vivid dreams (common). Mild cognitive side effects in some users — brain fog paradoxically (uncommon). Emotional blunting (uncommon)
What is the NSI-189 cycle protocol?
NSI-189 is typically cycled 8-12 weeks. Breaks recommended after cycling period
Questions reflect common community inquiries. This is not medical advice.